CINECA IRIS Institutional Research Information System

COSTELLI, Paola
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.755
EU - Europa 4.928
AS - Asia 3.818
OC - Oceania 170
SA - Sud America 156
AF - Africa 46
Continente sconosciuto - Info sul continente non disponibili 22
Totale 16.895
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.586
CN - Cina 1.964
DE - Germania 1.183
IT - Italia 893
IE - Irlanda 602
SG - Singapore 575
FR - Francia 391
KR - Corea 350
JP - Giappone 308
FI - Finlandia 305
GB - Regno Unito 301
SE - Svezia 280
UA - Ucraina 256
VN - Vietnam 183
PL - Polonia 168
AU - Australia 162
CA - Canada 149
BR - Brasile 120
TW - Taiwan 118
ES - Italia 95
HK - Hong Kong 74
AT - Austria 69
ID - Indonesia 68
BE - Belgio 65
NL - Olanda 63
IN - India 57
CH - Svizzera 42
RU - Federazione Russa 40
DK - Danimarca 39
NO - Norvegia 32
TR - Turchia 28
PT - Portogallo 27
EU - Europa 21
GR - Grecia 21
MO - Macao, regione amministrativa speciale della Cina 18
MX - Messico 18
TH - Thailandia 16
CO - Colombia 13
ET - Etiopia 12
IR - Iran 12
CL - Cile 11
LT - Lituania 11
SA - Arabia Saudita 11
HU - Ungheria 10
SN - Senegal 10
IL - Israele 9
RO - Romania 9
AR - Argentina 8
NZ - Nuova Zelanda 8
MY - Malesia 7
NG - Nigeria 7
ZA - Sudafrica 6
BD - Bangladesh 5
CZ - Repubblica Ceca 4
SI - Slovenia 4
BG - Bulgaria 3
EE - Estonia 3
EG - Egitto 3
NP - Nepal 3
RS - Serbia 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
BW - Botswana 2
IQ - Iraq 2
LU - Lussemburgo 2
MA - Marocco 2
MD - Moldavia 2
PK - Pakistan 2
ZM - Zambia 2
A1 - Anonimo 1
BT - Bhutan 1
CR - Costa Rica 1
CY - Cipro 1
GH - Ghana 1
GT - Guatemala 1
HR - Croazia 1
IM - Isola di Man 1
IS - Islanda 1
KH - Cambogia 1
KZ - Kazakistan 1
LV - Lettonia 1
MT - Malta 1
NE - Niger 1
PE - Perù 1
PH - Filippine 1
PS - Palestinian Territory 1
Totale 16.895
Salva come PNG Salva come JPEG
Città #
Santa Clara 847
Beijing 732
Chandler 650
Dublin 582
Fairfield 475
Singapore 459
Houston 414
Ann Arbor 301
Ashburn 300
Torino 259
Wilmington 222
Villeurbanne 216
Princeton 208
Woodbridge 196
Cambridge 190
Medford 186
Jacksonville 185
Seattle 185
Hangzhou 175
Columbus 166
Shanghai 158
Warsaw 152
Pisa 145
Redwood City 141
Nyköping 131
Dong Ket 111
Guangzhou 96
Dearborn 76
Nanjing 73
Taipei 68
Boston 65
Turin 63
Jakarta 58
Milan 55
Toronto 53
Vienna 53
Tokyo 52
Chengdu 44
Seoul 42
Nürnberg 40
Berlin 38
Wuhan 38
Rome 37
San Diego 37
Jinan 35
Norwalk 34
Boardman 33
Hefei 32
Sydney 32
Brussels 31
Melbourne 31
Fremont 30
Munich 30
Brisbane 27
Hong Kong 25
São Paulo 24
Changsha 23
Chicago 23
Los Angeles 23
Shenyang 23
Barcelona 22
Chongqing 22
Columbia 22
New York 22
Dallas 21
Verona 21
Falls Church 20
Helsinki 20
Madrid 20
Phoenix 20
Xian 20
Nuremberg 18
Duncan 17
London 17
Ottawa 17
Rochester 17
Silver Spring 17
Amsterdam 16
Evanston 16
Zhengzhou 16
Central District 15
Copenhagen 15
Montréal 15
San Jose 15
Central 14
Des Moines 14
Florence 14
Macao 14
Pittsburgh 14
Xiamen 14
Indianapolis 13
Nanchang 13
Nottingham 13
Oslo 13
Washington 13
Bethesda 12
Hanoi 12
Hebei 12
Kunming 12
Philadelphia 12
Totale 9.880
Salva come PNG Salva come JPEG
Nome #
Guidelines for the use and interpretation of assays for monitoring autophagy 1.820
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 680
Autophagy Exacerbates Muscle Wasting in Cancer Cachexia and Impairs Mitochondrial Function 480
Coming back: autophagy in cachexia 469
ß-hydroxy-ß-methylbutyrate (HMB) attenuates muscle and body weight loss in experimental cancer cachexia 466
Novel investigational drugs mimicking exercise for the treatment of cachexia 416
Autophagic degradation contributes to muscle wasting in cancer cachexia 412
JNK activation is required for TNFα-induced apoptosis in human hepatocarcinoma cells 316
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) 274
Cytotoxic properties of clofibrate and other peroxisome proliferators: relevance to cancer progression 257
Glutamine prevents myostatin hyperexpression and protein hypercatabolism induced in C2C12 myotubes by Tumor Necrosis Factor-alpha 240
MuRF-1 and p-GSK3β expression in muscle atrophy of liver cirrhosis 224
Changes in myostatin signaling in non weight-losing cancer patients 214
Mechanism-based therapeutic approaches to cachexia 213
Combination of exercise training and erythropoietin prevents cancer-induced muscle alterations 211
Effect of the specific proteasome inhibitor Bortezomib on cancer-related muscle wasting 204
Autophagy is induced in the skeletal muscle of cachectic cancer patients 196
Effects of chronic sugar consumption on lipid accumulation and autophagy in the skeletal muscle 195
Combined approach to counteract experimental cancer cachexia: eicosapentenoic acid and training exercise 193
Role of Inflammation in Muscle Homeostasis and Myogenesis 191
Improvement of skeletal muscle performance in ageing by the metabolic modulator Trimetazidine 182
Vitamin D and VDR in cancer cachexia and muscle regeneration 182
Agonist antibodies activating the Met receptor protect cardiomyoblasts from cobalt chloride-induced apoptosis and autophagy 169
New developments in investigational HDAC inhibitors for the potential multimodal treatment of cachexia 168
Epigenetic targeting of bromodomain protein BRD4 counteracts cancer cachexia and prolongs survival 154
Early changes of muscle IGF-1 and myostatin gene expression in gastric cancer patients 153
Muscle wasting and impaired myogenesis in tumor bearing mice are prevented by ERK inhibition 150
Erythropoietin administration partially prevents adipose tissue loss in experimental cancer cachexia models 148
Interference with Ca 2+ -dependent proteolysis does not alter the course of muscle wasting in experimental cancer cachexia 139
CASPASE 2 ACTIVATION AND ER STRESS DRIVE RAPID JURKAT CELL APOPTOSIS BY CLOFIBRATE 138
In vitro and in vivo conditional sensitization of hepatocellular carcinoma cells to TNF-induced apoptosis by Taxol 136
Moderate exercise improves experimental cancer cachexia by modulating the redox homeostasis 133
The mitochondrial metabolic reprogramming agent trimetazidine as an 'exercise mimetic' in cachectic C26-bearing mice 129
Apoptosis induced by clofibrate in Yoshida AH-130 hepatoma cells: role of HMG-CoA reductase. 128
Guidelines for the use and interpretation of assays for monitoring autophagy 126
Modulating metabolism to improve cancer-induced muscle wasting 123
Ca(2+)-dependent proteolysis in muscle wasting. 122
The Skeletal Muscle as an Active Player Against Cancer Cachexia 120
Anti-proliferative effects of an extra-virgin olive oil extract enriched in ligstroside aglycone and oleocanthal on human liver cancer cell lines 116
Phosphocaveolin-1 enforces tumor growth and chemoresistance in rhabdomyosarcoma 113
HGF receptor agonists protect cardiomyocytes from CoCl2-induced cell injury 113
4-Hydroxynonenal modulation of p53 family gene expression in the SK-N-BE neuroblastoma cell line 107
Animal models for cancer cachexia 105
Cancer-induced muscle wasting: Latest findings in prevention and treatment 101
Patogenesi dell'ipotrofia muscolare nella cachessia neoplastica: ruolo della via di segnalazione attivata da IGF-1 100
Circ-ZNF609: a novel regulator of myogenesis 99
Interleukin-4 administration improves muscle function, adult myogenesis, and lifespan of colon carcinoma-bearing mice 99
Point mutated Caveolin-3 form (P104L) impairs myoblast differentiation via Akt and p38 signalling reduction, leading to an immature cell signature 95
HGF receptor agonists protect cardiomyocytes from CoCl2-induced cell injury 95
Modulations of the calcineurin/NF-AT pathway in skeletal muscle atrophy 90
A CircRNA/miR axis contributes to hypoxia-induced cardiomyocyte death 87
Ca2+-dependent apoptosis in Jurkat cells treated with clofibrate 85
Beta-hydroxy-beta-methylbutyrate prevents weight and muscle loss in cancer cachexia 84
Differential modulation of TNfα-induced cell death by 3-methyladenine, an autophagy inhibitor. 84
Anticytokine treatment prevents the increase in the activity of ATP-ubiquitin- and Ca2+-dependent proteolytic systems in the muscle of tumour-bearing rats 83
Differential modulation of TNf alpha-induced cell death by 3-methyladenine, an autophagy inhibitor 83
Muscle atrophy in experimental cancer cachexia: is the IGF-1 signaling pathway involved? 81
Anticytokine strategies for the treatment of cancer-related anorexia and cachexia 80
Deacetylase inhibitors modulate the myostatin/follistatin axis without improving cachexia in tumor-bearing mice 79
Activation of Ca2+-dependent proteolysis in skeletal muscle and heart in cancer cachexia 78
La somministrazione di idrossi-metil-butirrato previene la perdita di peso e di muscolo in un modello sperimentale di cachessia neoplastica 78
Are there any benefits for exercise training in cancer cachexia? 78
Altered pattern of lipid metabolism in patients with lung cancer 76
Cancer cachexia: metabolic alterations and therapeutic approaches in an experimental model 76
Targeting mitochondria by ss-31 ameliorates the whole body energy status in cancer-and chemotherapy-induced cachexia 76
Are antioxidants useful to treat skeletal muscle atrophy? 75
Modulating the metabolism by trimetazidine enhances myoblast differentiation and promotes myogenesis in cachectic tumorbearing c26 mice 73
Rapid and extensive lethal action of clofibrate on hepatoma cells in vitro 72
Anti-TNF treatment reverts increased muscle ubiquitin gene expression in tumour-bearing rats 72
Cancer cachexia: from experimental models to patient management 69
Alpha-adrenergic receptors may contribute to the hypertriglyceridemia associated with tumuor growth 69
Alterations of lipid and cholesterol metabolism in cahectic tumor-bearing rats are prevented by insulin 69
Extracellular vesicles derived from tumour cells as a trigger of energy crisis in the skeletal muscle 69
Consensus definition of sarcopenia, cachexia and pre-cachexia: Joint document elaborated by Special Interest Groups (SIG) "cachexia-anorexia in chronic wasting diseases" and "nutrition in geriatrics" 68
L'inibizione del sistema proteolitico ATP-ubiquitina dipendente non previene la perdita di massa muscolare in un modello sperimentale di cachessia neoplastica 67
MODULATIONS OF MYOSTATIN IN CANCER CACHEXIA. 66
The calpain system is modulated in experimental cancer cachexia 66
Anti-TNF treatment interferes with changes in lipid metabolism in a tumour cachexia model 65
Peroxisome proliferators induce apoptosis in hepatoma cells. 63
Moderate exercise in mice improves cancer plus chemotherapy-induced muscle wasting and mitochondrial alterations 63
Strategies for Reducing Salt and Sugar Intakes in Individuals at Increased Cardiometabolic Risk 63
Protein kinases in the pathogenesis of muscle wasting 62
Combined Exercise Training Positively Affects Muscle Wasting in Tumor-bearing Mice 62
Effect of dehydroepiandrosterone in the prevention of cancer- and diabetes-induced cachexia 61
Mice lacking TNFa receptors 1 and 2 are resistant to death and fulminant liver injury induced by agonistic anti-Fas antibody 61
Selective up-regulation of tumor necrosis factor receptor I in tumor-bearing rats with cancer-related cachexia 60
PERTURBATIONS OF THE IGF-1 SYSTEM IN CANCER CACHEXIA 59
Resveratrol does not ameliorate muscle wasting in different types of cancer cachexia models. 59
Statins, coenzyme Q10 and cachexia: what’s the link? 56
Myostatin blockade by deacetylase inhibitors fails to counteract muscle wasting in tumor-bearing mice 55
The cytosolic sialidase Neu2 is degraded by autophagy during myoblast atrophy 54
The redox balance: a target for interventions against muscle wasting in cancer cachexia? 54
Tumour growth influences skeletal muscle protein turnover in the pregnant rat 53
Muscle wasting in diabetic and in tumor-bearing rats: Role of oxidative stress 52
MYOSTATIN EXPRESSION IS UPREGULATED IN CANCER CACHEXIA. 52
Nutritional support in cancer 52
Understanding the mechanisms of muscle wasting to improve the management of several pathologies 52
Pharmacological inhibition of the ubiquitin/proteasome ATP-dependent system does not prevent muscle wasting in experimental cancer cachexia 51
Effects of proteasome inhibition in an experimental model of cancer cachexia 51
MUSCLE IGF-1 GENE EXPRESSION IS DOWNREGULATED IN EXPERIMENTAL CANCER CACHEXIA 50
Totale 14.857
Salva come PNG Salva come JPEG
Categoria #
all - tutte 44.766
article - articoli 0
book - libri 0
conference - conferenze 4.280
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.046
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.135 0 0 0 0 0 0 256 179 245 185 165 105
2020/20211.674 137 113 157 91 135 95 132 93 153 181 116 271
2021/20221.887 85 92 109 137 152 137 132 114 82 128 314 405
2022/20232.483 310 197 97 207 232 574 189 127 272 53 125 100
2023/20241.466 158 206 110 117 115 114 94 99 33 119 106 195
2024/20252.133 80 230 145 297 1.056 317 8 0 0 0 0 0
Totale 17.431